Chitotriosidase and soluble IL‐2 receptor: Comparison of two markers of sarcoidosis severity

References

• Baughman R. P., Lower E. E., du Bois R. M. Sarcoidosis. Lancet 2003; 361: 1111–18
   PubMed Web of Science ®Google Scholar
• Rottoli P., Bargagli E. Is bronchoalveolar lavage obsolete in the diagnosis of interstitial lung disease?. Curr Opin Pulm Med 2003; 9: 418–25
   PubMed Web of Science ®Google Scholar
• Judson M. A., Baughman R. P., Thompson B. W., et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 204–11
   PubMed Web of Science ®Google Scholar
• Ziegenhagen M. W., Rothe M. E., Schlaak M., Muller‐Quernheim J. BAL and sierological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003; 21: 407–13
   PubMed Web of Science ®Google Scholar
• Rottoli P., Magi B., Perari M. G., et al. Cytokine profile and proteome analysis in BAL of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005; 5: 1423–30
   PubMed Web of Science ®Google Scholar
• Kantrow S. P., Meyer K. C., Kidd P., Raghu G. The CD4/CD8 ratio in BAL fluid is highly variable. Eur Respir J 1997; 10: 2716–21
   PubMed Web of Science ®Google Scholar
• Agostini C., Trentin L., Facco M., et al. Role of IL‐15, IL‐2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996; 157: 910–18
   PubMed Web of Science ®Google Scholar
• Straub J. P., van Kamp G. J., van Maarsseveen T. C., Stam J. Biochemical parameters in BAL of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1995; 12: 51–7
   Google Scholar
• Lieberman J. Elevation of serum angiotensin‐converting enzyme (ACE) level in sarcoidosis. Am J Med 1975; 59: 365
   PubMed Web of Science ®Google Scholar
• Moller D. R. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis 1999; 16: 24–31
   PubMed Web of Science ®Google Scholar
• Studdy P. R., Lapworth R., Bird R. Angiotensin‐converting enzyme and its clinical significance: a review. J Clin Pathol 1983; 36: 938–47
   PubMed Web of Science ®Google Scholar
• Lieberman J., Schleissner L. A., Nosal A., Sastre A., et al. Clinical correlations of serum angiotensin‐converting enzyme in sarcoidosis. A longitudinal study of serum ACE, 67 Gallium scans, chest roentgenograms and pulmonary function. Chest 1983; 84: 522–8
   PubMed Web of Science ®Google Scholar
• Costabel U. Biochemistry. Sarcoidosis 1994; 438–9
   Google Scholar
• Sharma P., Smith I., Maguire G., et al. Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet 1997; 349: 1602–3
   PubMed Web of Science ®Google Scholar
• Gronhagen‐Riska C., Kuppa K., Fyhrquist F., et al. Angiotensin‐converting enzyme and lysozyme in silicosis and asbestosis. Scand J Respir Dis 1978; 59: 228–31
   PubMedGoogle Scholar
• Thomas A. V., Ansari A., Khurana M., et al. Elevated serum angiotensin‐converting enzyme in miliary tuberculosis. Am Rev Respir Dis 1979; 119: 83
   Google Scholar
• Lieberman J., Beutler E. Elevation of serum angiotensin‐converting enzyme in Gaucher's disease. N Engl J Med 1976; 294: 1442–4
   PubMed Web of Science ®Google Scholar
• Lieberman J., Sastre A. Serum angiotensin‐converting enzyme: elevations in diabetes mellitus. Ann Intern Med 1980; 93: 825–6
   PubMed Web of Science ®Google Scholar
• Smallridge R. C., Rogers J., Verma P. S. Serum angiotensin‐converting enzyme: alterations in hyperthyroidism, hypothyroidism and subacute thyroiditis. J Am Med Assoc 1983; 250: 2489–93
   PubMed Web of Science ®Google Scholar
• Ziegenhagen M. W., Rothe M. E., Schlaak M., Muller‐Quernheim J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003; 21: 407–13
   PubMed Web of Science ®Google Scholar
• Rothkrantz‐Kos S., Van Dieijen‐Visser M. P., Mulder P. G. H., Drent M. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem 2003; 49: 1510–17
   PubMed Web of Science ®Google Scholar
• Grutters J. C., Fellrath J. M., Mulder L., Janssen R., et al. Serum soluble IL2 receptor measurement in patients with sarcoidosis. Chest 2003; 124: 186–95
   PubMed Web of Science ®Google Scholar
• Grosso S., Margollicci M. A., Bargagli E., et al. Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Scand J Clin Lab Invest 2004; 64: 57–62
   PubMed Web of Science ®Google Scholar
• Van Eijk M., Van Roomen C. P., Renkema G. H., et al. Characterization of human phagocyte‐derived chitotriosidase: a component of innate immunity. Int Immunol 2005; 15: 1505–12
   Web of Science ®Google Scholar
• Wajner A., Michelin K., Burin M. G., et al. Biochemical characterisation of chitotriosidase enzyme. Comparison between normal individuals and patients with Gaucher and Niemann‐Pick disease. Clin Biochem 2004; 37: 893–7
   PubMed Web of Science ®Google Scholar
• Labadaridis I., Dimitriou E., Theodorakis M., et al. Chitotriosidase in neonates with fungal and bacterial infections. Arch Dis Child Fetal Neonatal Ed 2005; 90: 531–2
   PubMed Web of Science ®Google Scholar
• Altarescu G., Rudensky B., Abrahamov A., et al. Plasma chitotriosidase activity in patients with beta‐thalassemia. Am J Hematol 2003; 72: 285–6
   Web of Science ®Google Scholar
• Aguilera B., Ghauharali‐van der Vlugt K., Helmond M. T. J., et al. Transglycosidase activity of chitotriosidase. J Biol Chem 2003; 42: 40911–16
   Web of Science ®Google Scholar
• Bargagli E., Margollicci M., Perrone M., et al. Chitotriosidase levels in BAL of patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2007, In press
   PubMed Web of Science ®Google Scholar
• Bargagli E., Margollicci M. A., Nikiforakis N., et al. Chitotriosidase levels in serum of patients with sarcoidosis and pulmonary tuberculosis. Respiration 2007 Mar 7, In press
   PubMed Web of Science ®Google Scholar
• Bargagli E., Margollicci M. A., Luddi A., et al. Chitotriosidase in BAL of patients with diffuse lung diseases. Resp Med 2007, In press
   PubMed Web of Science ®Google Scholar
• Bargagli E., Rottoli P. Serum chitotriosidase activity in sarcoidosis patients. Rheumatol Int 2007; 27: 1187
   PubMed Web of Science ®Google Scholar
• Hunninghake W. G., Costabel U., Ando M., et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diff Lung Dis 1999; 160: 736–55
   Google Scholar
• Scadding J. G. Prognosis of intrathoracic sarcoidosis in England. Br J Med 1961; 2: 1165–72
   PubMed Web of Science ®Google Scholar
• Rottoli P., Magi B., Perari M. G., et al. Cytokine profile and proteome analysis in BAL of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005; 5: 1423–30
   PubMed Web of Science ®Google Scholar
• Malaguarnera L., Musumeci M., Di Rosa M., Scuto A., et al. Interferon‐gamma, tumour necrosis factor‐alpha and lipopolysaccharide promote chitotriosidase gene expression in human macrophages. J Clin Lab Anal 2005; 19: 128–32
   PubMed Web of Science ®Google Scholar
• Drent M., Costabel U. Sarcoidosis. European Respiratory Monograph 2005; 10: 13
   Google Scholar
• Sengpiel A. L., Jaksztat E., Welker L., et al. Effect of beclomethasone dipropionate (BDP) as extrafine aerosol on bronchoalveolar lavage (BAL) lymphocytes in chronic sarcoidosis. Sarcoidosis Vasc Diff Lung Dis 2005; 22: 214–21
   PubMed Web of Science ®Google Scholar
• Papakosta D., Kyriazis G., Gioulekas D., et al. Variations in alveolar cell populations, lymphocyte subsets and NK‐cells in different stages of active pulmonary sarcoidosis. Sarcoidosis Vasc Diff Lung Dis 2005; 22: 21–6
   PubMed Web of Science ®Google Scholar
• Baughman R. P., Lower E., Bradley D., Raymond L. A., et al. Etanercept for refractory ocular sarcoidosis. Chest 2005; 128: 1062–7
   PubMed Web of Science ®Google Scholar